Learning from serosurveillance for SARS-CoV-2 to inform pandemic preparedness and response
Sophie Alice Müller, Ambrose Agweyu, Olusola Anuoluwapo Akanbi, Mary A. Alex-Wele, Kokou Nouwame Alinon, Rahul K. Arora, Saidou Balam, Bernard Barekye, Amen Ben Hamida, Isabel Bergeri, Nicki L. Boddington, Lena Böff, Idesbald Boone, Andelé M. Conradie, Anahit Demirchyan, Sandra Dudareva, Charbel El Bcheraoui, Megan Evans, Elise Farley, Iris Hunger, Jefferson M. Jones, E. Wangeci Kagucia, Makobu Kimani, Hannah C. Lewis, Festo Mazuguni, Solomon Mwakasungula, Jason M. Mwenda, Olena Nesterova, Emmanuel Nepolo, Natasha Nghitukwa, James Nyagwange, Ruth Offergeld, Tochi Okwor, Felix Reichert, S Sahakyan, Sabah Shaikh, Kaveto Sikuvi, Sabrina Weiß, Mairead Whelan, Christian Winter, Abdhalah Ziraba, Johanna Hanefeld
Topics & Concepts
SeroprevalencePandemicPreparednessPublic healthScopusPopulationPolitical scienceCoronavirus disease 2019 (COVID-19)MedicineEconomic growthGeographyFamily medicineMEDLINEEnvironmental healthDiseaseNursingSerologyInfectious disease (medical specialty)EconomicsPathologyLawAntibodyImmunologySARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesViral Infections and Outbreaks Research